Lifeward Ltd. Ordinary Shares (LFWD)
Stock · NASDAQ · Health Care
$6as of 10/16/2026
Price chart
LFWD Signal Track Record
How signals performed across all stocks →What LFWD's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 25 | -1.5% | 44% | September 30, 2026 |
| Bollinger Band Breakout | 16 | -8.3% | 13% | June 30, 2026 |
| Volume Spike | 12 | -13.9% | 17% | July 7, 2026 |
| 200-Day Moving Average TouchActive now | 11 | -3.6% | 45% | September 1, 2026 |
| Any 20-session window (baseline) | -5.4% | 36% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About LFWD
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore…
- Sector
- Health Care
- Industry
- Industrial Specialties
- Employees
- 81
- Website
- golifeward.com/
Fundamentals
- 1-day range
- $6.15$6.25
- Market cap
- $20.93M
- P/E (trailing)
- —
- P/E (forward)
- -7.23
- EPS (trailing)
- $-16.78
- Dividend yield
- —
- Beta
- 0.57
- Avg. volume
- 5.9K
- Dividend pay date
- April 1, 2019
How Lifeward Ltd. Ordinary Shares Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 18, 2026 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
Lifeward Ltd. Ordinary Shares Competitors
Chosen by industry and closest market cap.
- LFWDLifeward Ltd. Ordinary Shares$6▼ 0.99%Market cap $20.93MP/E —$4.14$9.84
- TLIHTen-League International Holdings Limited Ordinary Shares$5.55▼ 3.14%Market cap $16.94MP/E 2.95$2.2$6.74
- BBLGWBone Biologics Corp Warrants$7.7▲ 0.00%Market cap $13.94MP/E —$3.5$35.95
- RGNTRegentis Biomaterials Ltd. Ordinary Shares$1.49▼ 3.87%Market cap $13.84MP/E —$1.23$15.5
- FGIFGI Industries Ltd. Ordinary Shares$7.49▼ 0.27%Market cap $9.13MP/E —$3.14$19.93
- CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares$1.9▼ 2.56%Market cap $8.98MP/E —$1.45$14.8
- HSCSHeartSciences Inc. Common Stock$3.02▼ 5.03%Market cap $7.80MP/E —$1.63$5.25
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| LFWD Lifeward Ltd. Ordinary Shares | $20.93M | — | $6 | ▼ 0.99% | $4.14$9.84 |
| TLIH Ten-League International Holdings Limited Ordinary Shares | $16.94M | 2.95 | $5.55 | ▼ 3.14% | $2.2$6.74 |
| BBLGW Bone Biologics Corp Warrants | $13.94M | — | $7.7 | ▲ 0.00% | $3.5$35.95 |
| RGNT Regentis Biomaterials Ltd. Ordinary Shares | $13.84M | — | $1.49 | ▼ 3.87% | $1.23$15.5 |
| FGI FGI Industries Ltd. Ordinary Shares | $9.13M | — | $7.49 | ▼ 0.27% | $3.14$19.93 |
| CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | $8.98M | — | $1.9 | ▼ 2.56% | $1.45$14.8 |
| HSCS HeartSciences Inc. Common Stock | $7.80M | — | $3.02 | ▼ 5.03% | $1.63$5.25 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Lifeward Informed By Rami Aviram That He Will Not Assume CFO Role; Josh Hexter To Continue As Interim Principal Financial Officer, Principal Accounting OfficerBenzinga · 10/8/2026
- Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and PainYahoo · 9/15/2026
- Lifeward Announces Publication Of Researcher-Led Peer-Reviewed Study Showing Potential For Individuals With Chronic Spinal Cord Injury To Use Personal Exoskeleton To Perform Everyday ActivitiesBenzinga · 9/15/2026
- Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And MoreSeekingAlpha · 9/11/2026
Insider Activity
Insider Actions →- Avraham Gabay · August 20, 2026 · Grant13.6K
- Zamir Haggai · August 14, 2026 · Grant6.7K
- Greenwald Yonason · August 14, 2026 · Grant6.7K
- Keith Dale Rose · May 1, 2026 · Grant15.0K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
LFWD CFO Succession Update: Aviram Declines Role, Hexter Continues
Lifeward Ltd. said that Rami Aviram will not take on the CFO position. Josh Hexter will remain the interim principal financial officer and principal accounting officer. The announcement keeps the company’s financial leadership stable while a permanent CFO is sought.
LFWD CFO Succession Update: Aviram Declines Role, Hexter Continues. Lifeward Ltd. said that Rami Aviram will not take on the CFO position. Josh Hexter will remain the interim principal financial officer and principal accounting officer. The announcement keeps the company’s financial leadership stable while a permanent CFO is sought.